The pharmaceutical industry relies heavily on the precise construction of molecules to develop effective and safe drugs. Central to this are chiral intermediates, compounds possessing a non-superimposable mirror image, often critical for a drug's biological activity. One such vital compound is (S)-4-Chloro-3-hydroxybutyronitrile (CAS: 127913-44-4).

As a key chiral pharmaceutical intermediate, (S)-4-Chloro-3-hydroxybutyronitrile plays a significant role in the synthesis of various complex organic molecules. Its specific stereochemistry is often preserved through multiple synthesis steps, ultimately contributing to the enantiomeric purity of the final Active Pharmaceutical Ingredient (API). The demand for such intermediates highlights the need for reliable suppliers capable of ensuring consistent quality and purity. For those looking to buy (S)-4-Chloro-3-hydroxybutyronitrile, understanding its properties and sourcing it from reputable sources is paramount.

A notable application for this intermediate is in the synthesis of Russellvastatin intermediates. Russellvastatin is a cholesterol-lowering drug, and the efficiency and success of its synthesis are directly linked to the quality of the intermediates used. Sourcing (S)-4-Chloro-3-hydroxybutyronitrile from a trusted chemical intermediate supplier in China, like NINGBO INNO PHARMCHEM CO.,LTD., ensures that manufacturers have access to a high-purity product. This not only aids in achieving the desired stereochemistry but also simplifies production processes.

The chemical properties of (S)-4-Chloro-3-hydroxybutyronitrile, such as its light yellow transparent liquid appearance and molecular formula C4H6ClNO, are important considerations for chemists. Understanding the 127913-44-4 intermediate properties aids in designing optimal reaction conditions and purification strategies. Pharmaceutical companies and research institutions prioritize materials that guarantee predictable outcomes in their synthesis pathways. Therefore, partnering with a supplier that emphasizes rigorous quality control is essential for advancing drug discovery and development.